Limited coverage drugs – cyproterone

Last updated on August 20, 2024
Generic name Strength Form

cyproterone

100 mg/1 mL ampoule

cyproterone

50 mg tablet

Special Authority criteria

Approval period

Indication of need to reduce aggressive sexual drive

Indefinite

Practitioner exemptions

  • None

Special notes

  • Criteria applicable for all plans including Plan G
  • For any cancer related condition, please contact the British Columbia Cancer Agency at 604-877-6098 Ext. 4610

Special Authority request form(s)